A randomized, double-blind, phase III study comparing two doses of erlotinib for second-line treatment of current smokers with advanced non-small-cell lung cancer (CurrentS)
Titel:
A randomized, double-blind, phase III study comparing two doses of erlotinib for second-line treatment of current smokers with advanced non-small-cell lung cancer (CurrentS)
Auteur:
Smit, Egbert F. Wu, Yi-Long Gervais, Radj Zhou, Caicun Felip, Enriqueta Feng, Jifeng Guclu, Salih Zeki Hoiczyk, Mathias Dorokhova, Elena Freudensprung, Ulrich Grange, Susan Perez-Moreno, Pablo Diego Mitchell, Lada Reck, Martin